Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Noncutaneous neoplasms after kidney transplantation: analysis at single center.

Rocha A, Malheiro J, Fonseca I, Martins LS, Dias L, Almeida M, Pedroso S, Henriques AC.

Transplant Proc. 2013 Apr;45(3):1102-5. doi: 10.1016/j.transproceed.2013.02.005.

PMID:
23622637
2.

Malignancy in Kidney Transplantation: A 25-Year Single-center Experience in Portugal.

Aguiar B, Santos Amorim T, Romãozinho C, Santos L, Macário F, Alves R, Campos M, Mota A.

Transplant Proc. 2015 May;47(4):976-80. doi: 10.1016/j.transproceed.2015.03.039.

PMID:
26036498
3.

Malignancies after kidney transplantation: a 40-year single-center experience in Korea.

Hwang JK, Moon IS, Kim JI.

Transpl Int. 2011 Jul;24(7):716-21. doi: 10.1111/j.1432-2277.2011.01270.x. Epub 2011 May 16.

4.

Malignancy after kidney transplantation: results of 400 patients from a single center.

Stratta P, Morellini V, Musetti C, Turello E, Palmieri D, Lazzarich E, Cena T, Magnani C.

Clin Transplant. 2008 Jul-Aug;22(4):424-7. doi: 10.1111/j.1399-0012.2008.00802.x. Epub 2008 Feb 27.

PMID:
18312442
5.

Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.

Tanabe K, Takahashi K, Sonda K, Tokumoto T, Ishikawa N, Kawai T, Fuchinoue S, Oshima T, Yagisawa T, Nakazawa H, Goya N, Koga S, Kawaguchi H, Ito K, Toma H, Agishi T, Ota K.

Transplantation. 1998 Jan 27;65(2):224-8.

PMID:
9458019
6.

De novo malignancies after kidney transplantation.

Hung YM, Chou KJ, Hung SY, Chung HM, Chang JC.

Urology. 2007 Jun;69(6):1041-4.

PMID:
17572182
7.

Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.

Triemer HL, Pearson TC, Odom KL, Larsen CP.

Clin Transplant. 2000 Aug;14(4 Pt 2):413-20.

PMID:
10946781
8.

Malignancy after heart transplantation: analysis of 24-year experience at a single center.

Yagdi T, Sharples L, Tsui S, Large S, Parameshwar J.

J Card Surg. 2009 Sep-Oct;24(5):572-9. doi: 10.1111/j.1540-8191.2009.00858.x. Epub 2009 May 28.

PMID:
19486222
9.

De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.

Apel H, Walschburger-Zorn K, Häberle L, Wach S, Engehausen DG, Wullich B.

Clin Transplant. 2013 Jan-Feb;27(1):E30-6. doi: 10.1111/ctr.12050. Epub 2012 Dec 27.

PMID:
23278453
10.

Advantages of kidney transplant precocity in graft long-term survival.

Malho A, Malheiro J, Fonseca I, Martins LS, Pedroso S, Almeida M, Dias L, Castro Henriques A, Cabrita A.

Transplant Proc. 2012 Oct;44(8):2344-7. doi: 10.1016/j.transproceed.2012.07.030.

PMID:
23026589
11.

High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan.

Wu MJ, Lian JD, Yang CR, Cheng CH, Chen CH, Lee WC, Shu KH, Tang MJ.

Am J Kidney Dis. 2004 Jun;43(6):1091-7.

PMID:
15168390
12.

Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.

Ju MK, Joo DJ, Kim SJ, Huh KH, Kim MS, Jeon KO, Kim HJ, Kim SI, Kim YS.

Transpl Int. 2009 Jun;22(6):644-53. doi: 10.1111/j.1432-2277.2009.00846.x. Epub 2009 Feb 10.

13.

Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.

Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, Zak M, Rakela J, Irish W, Fung JJ.

Transplantation. 1998 Nov 15;66(9):1193-200.

PMID:
9825817
15.

A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening.

Johnson EE, Leverson GE, Pirsch JD, Heise CP.

J Gastrointest Surg. 2007 Mar;11(3):272-9.

PMID:
17458597
16.

Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.

Øien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I.

Transplantation. 2007 Mar 15;83(5):600-6.

PMID:
17353781
17.

[Delayed graft function and its impact on the antigraft response after cadaver kidney transplantation].

Rainiene T, Asakiene E, Zelvys A, Dainys B.

Medicina (Kaunas). 2005;41 Suppl 1:101-6. Lithuanian.

18.
19.

Donor-recipient age difference and graft survival in living donor kidney transplantation.

Lee YJ, Chang JH, Choi HN, Jung JY, Kim YS, Chung WK, Park YH, Lee HH.

Transplant Proc. 2012 Jan;44(1):270-2. doi: 10.1016/j.transproceed.2011.12.013.

PMID:
22310630
20.

Half-life and risk factors for kidney transplant outcome--importance of death with function.

Matas AJ, Gillingham KJ, Sutherland DE.

Transplantation. 1993 Apr;55(4):757-61.

PMID:
8475549
Items per page

Supplemental Content

Write to the Help Desk